Surgical bypass versus metallic stent for unresectable pancreatic cancer

Dong Maosheng, Ohtsuka Takao, Jiro Ohuchida, Ken Inoue, Kazunori Yokohata, Koji Yamaguchi, Kazuo Chijiiwa, Masao Tanaka

研究成果: ジャーナルへの寄稿記事

46 引用 (Scopus)

抄録

With the development of interventional radiology and endoscopy, the practice of inserting expandable metallic stents for malignant jaundice has become widespread. Many studies have compared surgical bypass with polyethylene stents, or metallic stents with polyethylene stents. However, few data are available on the comparison of surgical bypass and metallic stents. The aim of this study was to compare the patient's postprocedure course and the cost performance of surgical bypass and metallic stents in patients with unresectable pancreatic cancer. The parameters analyzed were the rates of procedural and therapeutic success, duration of hospital stay, prevalence of early and late complications, cost performance, and prognosis. The rates of procedural and therapeutic success were excellent with both palliative treatments. With surgical bypass, there was a low prevalence of late complications, but duodenal obstruction sometimes occurred in patients without gastric bypass. With metallic stents, there was shorter hospitalization and lower cost, but a higher prevalence of late complications. Stent occlusion tended to occur in patients with uncovered metallic stents. There was no difference in the prognosis between the two palliative treatments. Thus, in consideration of the poor prognosis of pancreatic cancer, in patients with unresectable pancreatic cancer, insertion of covered metallic stents would be preferable to surgical bypass, because of the subsequent short hospitalization and the low cost. On the other hand, in patients with a relatively long expected prognosis, or in those with existing duodenal obstruction, biliary bypass with gastrojejunostomy may provide an advantage.

元の言語英語
ページ(範囲)367-373
ページ数7
ジャーナルJournal of Hepato-Biliary-Pancreatic Surgery
8
発行部数4
DOI
出版物ステータス出版済み - 12 1 2001

Fingerprint

Pancreatic Neoplasms
Stents
Duodenal Obstruction
Costs and Cost Analysis
Gastric Bypass
Polyethylene
Palliative Care
Hospitalization
Interventional Radiology
Jaundice
Endoscopy
Length of Stay
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hepatology

これを引用

Maosheng, D., Takao, O., Ohuchida, J., Inoue, K., Yokohata, K., Yamaguchi, K., ... Tanaka, M. (2001). Surgical bypass versus metallic stent for unresectable pancreatic cancer. Journal of Hepato-Biliary-Pancreatic Surgery, 8(4), 367-373. https://doi.org/10.1007/s005340170010

Surgical bypass versus metallic stent for unresectable pancreatic cancer. / Maosheng, Dong; Takao, Ohtsuka; Ohuchida, Jiro; Inoue, Ken; Yokohata, Kazunori; Yamaguchi, Koji; Chijiiwa, Kazuo; Tanaka, Masao.

:: Journal of Hepato-Biliary-Pancreatic Surgery, 巻 8, 番号 4, 01.12.2001, p. 367-373.

研究成果: ジャーナルへの寄稿記事

Maosheng, D, Takao, O, Ohuchida, J, Inoue, K, Yokohata, K, Yamaguchi, K, Chijiiwa, K & Tanaka, M 2001, 'Surgical bypass versus metallic stent for unresectable pancreatic cancer', Journal of Hepato-Biliary-Pancreatic Surgery, 巻. 8, 番号 4, pp. 367-373. https://doi.org/10.1007/s005340170010
Maosheng, Dong ; Takao, Ohtsuka ; Ohuchida, Jiro ; Inoue, Ken ; Yokohata, Kazunori ; Yamaguchi, Koji ; Chijiiwa, Kazuo ; Tanaka, Masao. / Surgical bypass versus metallic stent for unresectable pancreatic cancer. :: Journal of Hepato-Biliary-Pancreatic Surgery. 2001 ; 巻 8, 番号 4. pp. 367-373.
@article{8c3a111b6ae443c39cd0b344d4341dde,
title = "Surgical bypass versus metallic stent for unresectable pancreatic cancer",
abstract = "With the development of interventional radiology and endoscopy, the practice of inserting expandable metallic stents for malignant jaundice has become widespread. Many studies have compared surgical bypass with polyethylene stents, or metallic stents with polyethylene stents. However, few data are available on the comparison of surgical bypass and metallic stents. The aim of this study was to compare the patient's postprocedure course and the cost performance of surgical bypass and metallic stents in patients with unresectable pancreatic cancer. The parameters analyzed were the rates of procedural and therapeutic success, duration of hospital stay, prevalence of early and late complications, cost performance, and prognosis. The rates of procedural and therapeutic success were excellent with both palliative treatments. With surgical bypass, there was a low prevalence of late complications, but duodenal obstruction sometimes occurred in patients without gastric bypass. With metallic stents, there was shorter hospitalization and lower cost, but a higher prevalence of late complications. Stent occlusion tended to occur in patients with uncovered metallic stents. There was no difference in the prognosis between the two palliative treatments. Thus, in consideration of the poor prognosis of pancreatic cancer, in patients with unresectable pancreatic cancer, insertion of covered metallic stents would be preferable to surgical bypass, because of the subsequent short hospitalization and the low cost. On the other hand, in patients with a relatively long expected prognosis, or in those with existing duodenal obstruction, biliary bypass with gastrojejunostomy may provide an advantage.",
author = "Dong Maosheng and Ohtsuka Takao and Jiro Ohuchida and Ken Inoue and Kazunori Yokohata and Koji Yamaguchi and Kazuo Chijiiwa and Masao Tanaka",
year = "2001",
month = "12",
day = "1",
doi = "10.1007/s005340170010",
language = "English",
volume = "8",
pages = "367--373",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Surgical bypass versus metallic stent for unresectable pancreatic cancer

AU - Maosheng, Dong

AU - Takao, Ohtsuka

AU - Ohuchida, Jiro

AU - Inoue, Ken

AU - Yokohata, Kazunori

AU - Yamaguchi, Koji

AU - Chijiiwa, Kazuo

AU - Tanaka, Masao

PY - 2001/12/1

Y1 - 2001/12/1

N2 - With the development of interventional radiology and endoscopy, the practice of inserting expandable metallic stents for malignant jaundice has become widespread. Many studies have compared surgical bypass with polyethylene stents, or metallic stents with polyethylene stents. However, few data are available on the comparison of surgical bypass and metallic stents. The aim of this study was to compare the patient's postprocedure course and the cost performance of surgical bypass and metallic stents in patients with unresectable pancreatic cancer. The parameters analyzed were the rates of procedural and therapeutic success, duration of hospital stay, prevalence of early and late complications, cost performance, and prognosis. The rates of procedural and therapeutic success were excellent with both palliative treatments. With surgical bypass, there was a low prevalence of late complications, but duodenal obstruction sometimes occurred in patients without gastric bypass. With metallic stents, there was shorter hospitalization and lower cost, but a higher prevalence of late complications. Stent occlusion tended to occur in patients with uncovered metallic stents. There was no difference in the prognosis between the two palliative treatments. Thus, in consideration of the poor prognosis of pancreatic cancer, in patients with unresectable pancreatic cancer, insertion of covered metallic stents would be preferable to surgical bypass, because of the subsequent short hospitalization and the low cost. On the other hand, in patients with a relatively long expected prognosis, or in those with existing duodenal obstruction, biliary bypass with gastrojejunostomy may provide an advantage.

AB - With the development of interventional radiology and endoscopy, the practice of inserting expandable metallic stents for malignant jaundice has become widespread. Many studies have compared surgical bypass with polyethylene stents, or metallic stents with polyethylene stents. However, few data are available on the comparison of surgical bypass and metallic stents. The aim of this study was to compare the patient's postprocedure course and the cost performance of surgical bypass and metallic stents in patients with unresectable pancreatic cancer. The parameters analyzed were the rates of procedural and therapeutic success, duration of hospital stay, prevalence of early and late complications, cost performance, and prognosis. The rates of procedural and therapeutic success were excellent with both palliative treatments. With surgical bypass, there was a low prevalence of late complications, but duodenal obstruction sometimes occurred in patients without gastric bypass. With metallic stents, there was shorter hospitalization and lower cost, but a higher prevalence of late complications. Stent occlusion tended to occur in patients with uncovered metallic stents. There was no difference in the prognosis between the two palliative treatments. Thus, in consideration of the poor prognosis of pancreatic cancer, in patients with unresectable pancreatic cancer, insertion of covered metallic stents would be preferable to surgical bypass, because of the subsequent short hospitalization and the low cost. On the other hand, in patients with a relatively long expected prognosis, or in those with existing duodenal obstruction, biliary bypass with gastrojejunostomy may provide an advantage.

UR - http://www.scopus.com/inward/record.url?scp=0035236064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035236064&partnerID=8YFLogxK

U2 - 10.1007/s005340170010

DO - 10.1007/s005340170010

M3 - Article

C2 - 11521183

AN - SCOPUS:0035236064

VL - 8

SP - 367

EP - 373

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 4

ER -